Sana Biotechnology (SANA) Financials

INSTRUMENT_FINANCIALS provide a comprehensive view of Sana Biotechnology, Inc.'s financial performance. The income statement reveals the company's revenues, expenses, and net income from stockholders. It shows how much money the company generated and the costs it incurred during a specific period. Sana Biotechnology, Inc. (SANA) total revenue represents the combined income from various sources. This figure indicates the scale of the company's operations and its ability to generate revenue. Gross profit is the difference between total revenue and the cost of goods sold, excluding other expenses. It indicates the profitability of Sana Biotechnology, Inc.'s core operations.

The balance sheet provides a snapshot of Sana Biotechnology, Inc.'s financial position at a specific point in time. It includes information about the company's assets, liabilities, and stockholders' equity. Total assets represent the value of all resources owned by the company, including cash equivalents, property, and investments. On the other hand, total liabilities include the company's debts and obligations. Stockholders' equity represents the shareholders' ownership interest in the company. Net debt is calculated by subtracting cash and cash equivalents from total debt, providing insight into Sana Biotechnology, Inc.'s debt burden and its ability to meet financial obligations.

Cash flow statements detail the inflows and outflows of cash for Sana Biotechnology, Inc. (SANA). Operating cash flow represents the cash generated or used by the company's core operations, reflecting its ability to generate cash from day-to-day activities. Investing cash flow shows the cash used for acquiring or selling assets, such as property, equipment, or investments. Financing cash flow reflects the cash obtained or paid out for activities like issuing or repurchasing stock, paying dividends, or repaying loans. Free cash flow is a measure of the cash available for expansion or distribution to stockholders after deducting capital expenditures. It provides insight into Sana Biotechnology, Inc.'s financial flexibility and ability to invest in growth opportunities.